Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NASDAQ:OPK)

9.95
Delayed Data
As of Jul 29
 +0.06 / +0.61%
Today’s Change
7.12
Today|||52-Week Range
16.90
-1.00%
Year-to-Date
Where Is the Insider Buying?
Jul 25 / TheStreet.com - Paid Partner Content
Weekly CEO Buys: Akamai, Restoration Hardware
Jul 23 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close9.89
Today’s open9.89
Day’s range9.76 - 9.96
Volume2,153,115
Average volume (3 months)3,562,705
Market cap$5.4B
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)+85.37%
Earnings growth (this year)-5.55%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+439.63%
P/E ratio67.9
Price/Sales9.97
Price/Book2.74

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...-0.21-0.31%
UTHRUnited Therapeutics ...+2.02+1.70%
TAROTaro Pharmaceutical ...+0.02+0.01%
TSROTESARO Inc-0.38-0.41%
Data as of 4:02pm ET, 07/29/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)$0.00
Annual revenue (last year)$491.7M
Annual profit (last year)-$30.0M
Net profit margin-6.11%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer, Treasurer, CAO &
SVP
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts

Partner Offers

Search for Jobs